Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IM Cannabis Corp. (IMCC : NSDQ)
 
 • Company Description   
IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and Canada. IM Cannabis Corp. is headquartered in Israel.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.44 Daily Weekly Monthly
20 Day Moving Average: 1,132,610 shares
Shares Outstanding: 67.84 (millions)
Market Capitalization: $233.36 (millions)
Beta:
52 Week High: $11.63
52 Week Low: $1.56
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 50.22% 54.91%
12 Week 2.69% 1.67%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
KIBBUTZ GLIL YAM
-
TEL AVIV-YAFO,L3 -
ISR
ph: 972-54-668-7515
fax: -
None http://www.imcannabis.com
 
 • General Corporate Information   
Officers
Oren Shuster - Chief Executive Officer and Director
Marc Lustig - Chairman
Shai Shemesh - Chief Financial Officer
Yael Harrosh - Director
Richard Balla - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 44969Q208
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 04/22/22
Share - Related Items
Shares Outstanding: 67.84
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $233.36 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.15 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 04/22/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.39
Price/Cash Flow: -
Price / Sales: 7.49
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 26.32%
Sales Growth
vs. Year Ago Period: 158.44%
vs. Previous Quarter: 26.37%
ROE
09/30/21 - -19.57
06/30/21 - -20.56
03/31/21 - -35.43
ROA
09/30/21 - -14.00
06/30/21 - -13.99
03/31/21 - -22.77
Current Ratio
09/30/21 - 2.29
06/30/21 - 3.02
03/31/21 - 2.31
Quick Ratio
09/30/21 - 1.50
06/30/21 - 2.36
03/31/21 - 1.67
Operating Margin
09/30/21 - -60.79
06/30/21 - -62.31
03/31/21 - -102.09
Net Margin
09/30/21 - -60.79
06/30/21 - -62.31
03/31/21 - -102.09
Pre-Tax Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Book Value
09/30/21 - 2.47
06/30/21 - 1.74
03/31/21 - -
Inventory Turnover
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Equity
09/30/21 - 0.08
06/30/21 - 0.09
03/31/21 - 0.10
Debt-to-Capital
09/30/21 - 7.58
06/30/21 - 8.30
03/31/21 - 9.19
 

Powered by Zacks Investment Research ©